The Pim family of serine threonine protein kinases plays an important role in regulating both the growth and transformation of malignant cells. However, in a cell line dependent manner the over expression of PIM1 can inhibit cell and tumor growth. In 22Rv1 human prostate cells, but not in Du145 or RWPE-2, PIM1 over expression was associated with marked increases in cellular senescence, as demonstrated by changes in the levels of β-galactosidase (SA−β-Gal), p21, IL-6 and 8 mRNA and protein. During early cell passages PIM1 induced cellular polyploidy and as the passage number increased markers of DNA damage, including the level of γH2AX and CHK2 phosphorylation, were seen Coincident with these DNA damage markers, the level of p53 protein and genes transcriptionally activated by p53, such as p21, TP53INP1 and DDIT4, increased. In these 22Rv1 cells, the induction of p53 protein was not only associated with senescence, but also with a significant level of apoptosis. The importance of the p53 pathway to PIM1 driven cellular senescence was further demonstrated by the observation that expression of dominant-negative p53 (DN p53) or shRNA targeting p21 blocked the PIM1-induced changes in the DNA damage response and increases in SA-β-Gal activity. Likewise in a subcutaneous tumor model PIM1-induced senescence was rescued when the p53-p21 pathways are inactivated. Based on these results, PIM1 will have its most profound affects on tumorigenesis in situations where the senescence response is inactivated.
INTRODUCTION
The PIM family of serine/threonine protein kinases has been implicated in the initiation or progression of multiple cancer types. The PIMs were initially cloned as proviral integration sites in moloney murine leukemia virus (MoMuLV)-induced murine T-cell lymphomagenesis (1) (2) (3) . In transgenic mouse models the PIM family of protein kinases function as weak oncogenes stimulating T-cell lymphomas (1, 4) and can complement the activity of both c-MYC and AKT to enhance tumorigenesis (5) (6) (7) (8) . The induction of lymphomas in PIM containing mice is markedly enhanced by treatment of these animals with chemical carcinogens (9) or γ-irradiation (10). The PIM protein kinases are overexpressed in many human cancers including prostate cancer (11, 12) , lymphoma (13, 14) , leukemia (15) , head and neck squamous cell carcinomas (16, 17) , and pancreatic and colon cancers (18, 19) . In human prostate, expression of PIM1 is low in benign prostatic hypertrophy, moderate in high grant intraepithelial neoplasia, and increased in frank cancer (11, 20) . Both high Gleason grade and progression to aggressive metastatic prostate cancer has been associated with increased PIM levels (12, 21) . Overexpression of PIM1 in human prostate cancer cells markedly increases their growth as tumors in animals (22) .
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Trans-Lentiviral packaging system (Open Biosystems) were used to produce infectious lentiviruses accordingly with the manufacturer's protocol.
To generate 22Rv1, Du145, RWPE-1 and RWPE-2 stable pools which constitutively express PIM1, cells were plated [16] [17] [18] hours before transduction at 1 x 10 5 cells/60 cm plates and then infected with 5X10 4 retroviral particles in the presence of 8µg/ml Polybrene. After 6 hours of incubation, the virus-containing media was replaced with fresh medium, and on the next day, 400 µg/ml G418 was added to select stably infected cell population. After 10 days of selection, stable cell pools were established, and expression of PIM1 transgenes was verified by Western blot analysis.
For inducible PIM1 expression assays, 22Rv1 cells, Cos7 or TKO MEF cells were infected with lentiviruses encoding vector control (pTRIPz) or PIM1 (pTRIPz/PIM1) using ViraDuctin TM Lentivirus Transduction Kit (Cell Biolabs Inc., San Diego, CA, USA). Cells were selected with 5 µg/ml of puromycin for 12 days. Individual clones were isolated and cells were incubated with absence or presence of doxycycline (Dox) and analyzed for PIM1 expression by Western blotting.
Additional pools of 22Rv1 cells that overexpressed dominant negative p53 (DN p53) were established through retroviral transduction. Stable cell lines were derived from two individual clones expressing inducible PIM1 were infected with retroviruses encoding vector control (pLNCX) or DN p53 (pBabe/ DN p53) using the protocol described above. G418 (400 µg/ml) or hygromycin (500 µg/ml) were added to select stably infected cell populations expressing PIM1 and vector control or DN p53. After 10 days of selection, stable cell pools were established, cells were incubated with absence or presence of Dox, and expression of the transgenes was verified by Western blot analysis. with Dox (20 ng/ml) to induce PIM1 expression and analyzed by Western blotting for the existence of the p53-GFP fusion and PIM1 proteins.
RNA interference experiments
For p21 knockdown experiments 22Rv1 stable pools with constitutive expression of PIM1 (pLNCX/PIM1) or vector only (pLNCX) in late passage were transduced with lentiviruses encoding Tet/ON inducible control shRNA or p21 shRNA, as described. Dox
(1 µg/ml) was added one day after transduction to induce the expression of sh RNAs.
After selection with puromycin (4 µg/ml) for 10 days, cells were pooled and analyzed.
Cell growth assay
To carry out an MTT assays, cells were seeded in triplicates into 96-well plates (5 X 10 3 cells/well) and allowed to adhere overnight. At the indicated times, 5 mg/ml MTT [3-(4, 5-dimethylthyazolyl-2)-2, 5 -diphenyltetrazolium bromide] (Sigma) was added to the media at 1:5 dilution, incubated for 3 hours, supernatants were removed, and 100 µl/well of DMSO was added to dissolve intracellular purple formazan. Absorbance was then measured at 570 nm. To measure cell growth with crystal violet (51) , cells were plated in triplicates at 5 X 10 4 /well in 12-well plates and incubated for 10 days, fixed
DNA histogram analysis
The floating and adherent cells were harvested and combined, washed with PBS, and fixed with cold 70% ethanol and stored at -20 0 C. The cells were then washed with PBS and resuspended in 1 ml buffer containing 100 mM Tris pH7.4, 150 mM NaCl, 1 mM CaCl 2 , 0.5 mM MgCl 2 , 0.1% NP-40, 40 µg/ml RNase H, and 25 µg/ml propidium iodite. After incubation for a minumum of 30 min at room temperature, the cells were then analyzed with a FACScalibur flow cytometer using channel FL3.
Xenograft mouse models
To generate tumor xenografts, 22Rv1 early passage cells expressing the indicated transgenes were washed twice with PBS and the cell density was adjusted to 0.5 X 10 6 cells/50 µl in serum free DMEM media, an equal volume of Matrigel (BD Biosciences) was then added, and the cell suspension was injected into both the left and right dorsal flank of male Nu/nu nude mice (Charles River). On day 2 after cell implantation Doxycyclin (Dox) (1 µg/ml) was added into the drinking water supplemented with 5% To stain tumor xenografts, these tissues were first embedded in OCT and frozen cryostat sections (8-10µm) were prepared. Tissues were fixed for 7 min with freshly prepared 4% paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100 for 30 min, and blocked for 30 min in PBS/ 0.1% Triton X-100/5% heat inactivated goat serum.
Sections were immunostained with anti-Ki67 antibody (1:1000 dilution) for 1 h, and then incubated with cy3 conjugated secondary antibody (1: 1000 dilution) for an additional 1 h. Fluorescence was visualized with Nikon Eclipse E800 microscope and images were taken by Nikon digital sight DS 2 Mv camera using NIS element BR 2.30 software.
Statistical analysis
All experiments were repeated a minimum of twice and statistical analysis carried out using the Student's t test unless otherwise stated. (Fig. 1B) . The final passage cells were found to have a flat and spread morphology and to be β-galactosidase positive consistent with the suggestion that they had undergone senescence ( (Fig. 3D) . Using antibodies to γ-tubulin which stains centrosomes, passage 8 Cos7 over expressing PIM1 were examined for changes in centrosome number. By counting multiple cell fields, the fraction of Cos7 cells containing more than 2 centrosomes in PIM1 expressing cells was found to be greater than 20% compared to 5% for control cells expressing vector alone (Fig. 3E) . In this culture, cells with multiple centrosomes (row 1, arrows), tetraploid cells with four mitotic spindles (row 2, arrows), and polyploid cells with multiple centrosomes and mitotic spindles (row 3, arrows) are all visible. Although it is more difficult to identify centrosomes in fibroblasts, we repeated this experiment in embryo fibroblasts that were isolated from mice that were genetically engineered to knock out all of the three PIM isoforms (57) and then transfected to over express only PIM1. γ-tubulin staining of these cells demonstrated the induction of multiple centrosomes (Fig. S5) .
Transition of 22Rv1/PIM1 cells to senescent phenotype is associated with DNA damage and activation of the p53 pathway.
To evaluate whether the p53 pathway was activated in these PIM1 containing prostate cancer cells, we carried out qT-PCR analysis of mRNA from cells expressing PIM1 in early and late passage cells that constitutively expressed PIM1 (Fig. 1A) , and examined the levels of three p53 activated genes, p53 inducible nuclear protein 1 (TP53INP1) (58), DNA-damage inducible transcript 4 (DDIT4, also known as REDD1 (59)) and p21. We find that PIM1-expressing cells at late, but not at early passage, express marked increases in the p53-inducible genes including TP53INP1 and DDIT4.
The increase in p21 transcripts is statistically significant even at early passages but with Phosphorylation of CHK2 at threonine 68 is required for subsequent activation of p53 protein in response to DNA damage (37, 60) . Likewise histone H2AX is phosphorylated on serine 139 when double strands DNA damage occurs yielding the γH2AX form of this histone (61, 62) . A marked change in the level of phosphorylation of these proteins occurs in late passage PIM1 containing 22Rv1 cells and mirrors increases in the levels of the p21 protein (Fig. 4B) . Thus, in 22Rv1 prostate cancer cells long term PIM1 over expression appears to induce polyploidy and DNA damage that is associated with the activation of p53-inducible genes, and ultimately leads to both cellular senescence and apoptosis.
Expression of p53 dominant negative reduces polyploidy, prevents senescence and senescence-associated apoptosis in 22Rv1/PIM1 prostate cells.
To evaluate whether the activation of the p53 pathway is essential for the induction of cellular senescence by PIM1, we over expressed dominant negative (DN) p53 in the 22Rv1 cells that contained Dox-inducible PIM1 and then treated these cells with Dox (20 ng/ml). We find that in early passage cells DN p53 is capable of decreasing the level of the p53-inducible TP53INP-1 transcript and suppressing the induction of p21 RNA (Fig.   5A ). These results are consistent with reduction of p21 protein seen by Western blotting (Fig 5D) . As shown (Fig. 5D ) the cyclin B1 level is markedly decreased in cells expressing high levels of PIM, and this change is reversed by the over expression of DN p53. Finally, staining of these late passages PIM1 over expressing cells with β-galactosidase demonstrates that blocking p53 activity also prevents the induction of this marker of cell senescence by PIM1 (Fig.5E ).
Expression of DN p53 restores the ability of 22Rv1/PIM1 cells to grow as tumors
To examine the ability of DN p53 to regulate 22Rv1 tumor growth driven by (Fig. S5 ) with predictable changes in protein levels (Fig S5A) , Ki-67 ( Fig. S5B) , and SA-β-Gal (Fig. S5C) . (Fig. 7A ). This result is clearly seen when p53 and p53/PIM1 22Rv1 cells are allowed to grow for 10 days in tissue culture, and then fixed and stained with crystal violet (Fig. 7B) . This inhibition in cell growth could result from the affect of the PIM1 and p53 on elevating the levels of p21 (Fig. 7C) . Also, when both PIM1 and p53 were expressed simultaneously, β−galactosidase staining of these cell lines revealed significantly increased levels of cell senescence (Fig.7D) .
Activation of p53 inhibits cell growth and increases

Knockdown of p21 expression rescues cells from senescence.
The Cdk inhibitor p21 was first identified as an over expressed marker in senescent cells, and later found to be capable of regulating senescence in both normal and cancer cells. p21 mediates, in part, the affects of p53, although other genes are also involved (for review (64) in the p53-induced biologic changes. To examine the role of p21 in these cells, lentiviral vectors were used to transduce a Tet/ON inducible shRNA directed at p21 (sh-p21) or a control sequence (sh-c) into 22Rv1 cells constitutively expressing PIM1 or a control vector. This shRNA was successful in decreasing p21 levels in control and PIM1 containing cells (Fig. 8B ), but had no affect on the growth of 22Rv1 cells (Fig. 8A) . In contrast, the growth of PIM1 containing 22Rv1 cells was markedly stimulated (Fig. 8A ) by decreasing the p21 levels. In these cells, decreased p21 levels correlated with a markedly lower level of γ-H2AX ( (Fig.7) , also suggests that the activation of p53 pathway is capable of enhancing the PIM1-induced senescence response. Since PIM1 does not upregulate p27 (Fig.1, C Consistent with its activation of p53, our results indicate that PIM1-induces threefold increase in p21 mRNA level in early passage cells and a marked 12-16 fold increase in the levels of the p21 transcript PIM1 expressing prostate undergo senescence (Fig.1D,   Fig. 4A ). Previous data showed that PIM1 phosphorylates p21 protein on Thr   145   and on   Ser   146 thus promoting p21 protein stabilization in p53-null H1299 lung carcinoma cells (78) . Since the expression of DN p53 decreased the level of p21 protein in this model, we suggest that the elevation of p21 protein is largely driven by increased transcription of the p21 mRNA and not changes in protein stability (Fig.5 ). It cannot be ruled out that in early passage cells where major DNA damage has not taken place that small changes in p21 levels could be regulated by protein stability. We find that in early passage 22Rv1 cells that express relatively large amounts of PIM1, there was no highly significant change in p53 protein levels and no induction of the p53 target genes, TP53INP-1 and DDIT-4 (Fig.4A) . It is possible that small changes in p53 levels activated by PIM1 stabilization of the Mdm2-ARF complex (23) could be driving increases in transcription of p21, or as our earlier work suggested (79) that other signaling pathways, i.e. PKC, possibly regulated by PIM1 could be playing a role in modulating p21 mRNA levels.
The DNA damage signaling pathway connects cellular stresses to cellular senescence (80) . We analyzed the DNA damage response (DDR) in 22Rv1 PIM1
expressing cells by measuring phosphorylation of CHK2 and the minor histone H2AX (Fig. 4C) . In response to DNA damage H2AX becomes phosphorylated on serine 139
and CHK2 on threonine 68 by ATM (37, 60, 62) . Early passage cells do not induce changes in these two proteins, however in late passage cells both CHK2 phosphorylation and γH2AX expression are markedly increased (Fig.4, B) . Since CHK2 can marked by aberrant premature termination of replication fork progression leading DNA breakage, the DDR response, and the induction of senescence (34, 83) . Genomic instability and DNA damage have been observed in both early human precancerous lesions and tumors, and this instability is closely related with induction of DDR (84) .
As well, recent data showed that PIM1 kinase plays a central role in DNA damageevoked neuronal death by regulating aberrant neuronal cell cycle activation (85). Our results, (Fig.3 , Suppl. Immunofluorescence was performed using antibodies to H3-K9m (red) for detection of stress-associated heterochromatin foci (SAHF) foci, and DAPI staining (blue ) was used to visualize DNA. Both vector and PIM1 expressing cells were late passage (Fig. 1A) . expression were the same as in Fig. 5B . The levels of GAPDH serve as a loading control.
E, 22Rv1 cells studied in Fig. 5D were analyzed for β-galactosidase expression.
